BOCIC(SH:601696) Xin Lang Cai Jing·2026-01-05 03:05Group 1 - The core viewpoint of the news is that Beijing Baipusi Biotechnology Co., Ltd. has seen a stock price increase of 5.07%, reaching 56.74 CNY per share, with a total market capitalization of 9.486 billion CNY [1] - The company was established on July 22, 2010, and went public on October 18, 2021, focusing on providing key biological reagent products and technical services, with its main revenue sources being recombinant proteins (82.27%), antibodies and other reagents (12.88%), technical services (3.04%), and others (1.80%) [1] Group 2 - According to data, a fund under Bank of China Securities has heavily invested in Baipusi, with the Bank of China Health Industry Mixed Fund (002938) increasing its holdings by 42,300 shares in the third quarter, bringing its total to 141,300 shares, which constitutes 5.29% of the fund's net value [2] - The Bank of China Health Industry Mixed Fund was established on September 7, 2016, with a current scale of 159 million CNY, achieving a year-to-date return of 28.34%, ranking 3345 out of 8155 in its category [2]